Intraindividual difference in estimated GFR by creatinine and cystatin c, cognitive trajectories and motoric cognitive risk syndrome

Document Type

Journal Article

Publication Title

Nephrology Dialysis Transplantation

Volume

39

Issue

5

First Page

860

Last Page

872

PubMed ID

37930847

Publisher

Oxford University Press

School

School of Medical and Health Sciences

RAS ID

64640

Comments

Wang, J., Liu, Y., Jin, R., Zhao, X., Wu, Z., Han , Z., . . . Tao, L. (2024). Intraindividual difference in estimated GFR by creatinine and cystatin c, cognitive trajectories and motoric cognitive risk syndrome. Nephrology Dialysis Transplantation, 39(5), 860-872. https://doi.org/10.1093/ndt/gfad234

Abstract

Background: Intraindividual differences between estimated glomerular filtration rate (eGFR) based on cystatin C (eGFRcys) and creatinine (eGFRcr) can convey important clinical information regarding health status. However, the clinical implications of these differences (eGFRdiff) for risk of cognitive decline and motoric cognitive risk (MCR) syndrome remains unclear. We aimed to investigate the longitudinal associations of eGFRdiff with cognitive trajectories and incident MCR. Methods: Based on the China Health and Retirement Longitudinal Study, we identified two study subcohorts: one for cognitive trajectory follow-up (6423 participants, 2011-2018) and another for incident MCR follow-up (2477 participants, 2011-2015). The eGFRdiff was defined as eGFRcys-eGFRcr. Adjusted ordinal and binary logistic regression models were separately used to assess the associations of eGFRdiff with cognitive trajectories and incident MCR. We also performed discordance analyses for eGFRdiff versus eGFRcys, eGFRcr or eGFR based on both creatinine and cystatin C (eGFRcys-cr). Results: In the first subcohort, four distinct 7-year cognitive trajectories were identified. Each 1 standard deviation (SD) higher eGFRdiff (value for eGFRcys-eGFRcr) was associated with a lower risk of poorer cognitive trajectories {odds ratio 0.909 [95% confidence interval (CI) 0.877-0.942]}. In the second subcohort, 121 participants developed incident MCR after a 4-year follow-up. Each 1-SD higher eGFRdiff (value for eGFRcys-eGFRcr) was linked with a 25.3% (95% CI 16.6-33.2) decreased risk for MCR. The above associations persisted in individuals with normal kidney function. Additionally, the risk for cognitive decline and incident MCR was more strongly associated with eGFRcys than eGFRcr and eGFRcys-cr. For the discordance analyses, the 'discordantly high eGFRdiff/low eGFR' group but not the 'discordantly low eGFRdiff/high eGFR' exhibited a significantly lower risk of poorer cognitive trajectories and MCR compared with the concordant group. Conclusions: A large negative difference between eGFRcys and eGFRcr (eGFRcys < eGFRcr) was associated with a higher risk of cognitive decline and incident MCR. The eGFRdiff could capture additional valuable risk information beyond eGFRcys, eGFRcr and eGFRcys-cr.

DOI

10.1093/ndt/gfad234

Access Rights

subscription content

Link to Full Text

Share

 
COinS